Patents by Inventor Mehrak Kiankarimi

Mehrak Kiankarimi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoamine re-uptake inhibitors and methods relating thereto
    Publication number: 20060252818
    Abstract: Monoamine re-uptake inhibitors and more specifically serotonin and noradrenaline re-uptake inhibitors are disclosed that have utility in the treatment of disorders of the central or peripheral nervous system in both men and women. The compounds of this invention have the structure: wherein R1, R2, R3, R4, R5, R6, m, n, W, X, and Y are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts, esters and solvates thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for inhibiting monoamine re-uptake in a subject in need thereof.
    Type: Application
    Filed: May 5, 2006
    Publication date: November 9, 2006
    Inventors: Mehrak Kiankarimi, Sarah Hudson, Wesley Dwight, Warren Wade
  • Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
    Patent number: 7067509
    Abstract: Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers and pharmaceutically acceptable salts thereof, wherein n, R1, R2, R3, R4, R5, and R6 are as defined herein. Pharmaceutical compositions containing a compound of this invention, as well as methods relating to the use thereof, are also disclosed.
    Type: Grant
    Filed: March 8, 2004
    Date of Patent: June 27, 2006
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Val Goodfellow, Martin Rowbottom, Brian P Dyck, Junko Tamiya, Mingzhu Zhang, Jonathan Grey, Troy D Vickers, Mehrak Kiankarimi, Warren Wade, Sarah Clough, Joseph Pontillo, Dongpei Wu
  • Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
    Publication number: 20040259931
    Abstract: Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity.
    Type: Application
    Filed: March 8, 2004
    Publication date: December 23, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Val Goodfellow, Martin Rowbottom, Brian P. Dyck, Junko Tamiya, Mingzhu Zhang, Jonathan Grey, Troy D. Vickers, Mehrak Kiankarimi, Warren Wade, Sarah Clough Hudson